Log in
Enquire now
‌

US Patent 8952171 Compounds and uses thereof for the modulation of hemoglobin

Patent 8952171 was granted and assigned to Global Blood Therapeutics on February, 2015 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
Global Blood Therapeutics
Global Blood Therapeutics
Current Assignee
Global Blood Therapeutics
Global Blood Therapeutics
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
8952171
Patent Inventor Names
Qing Xu0
Zhe Li0
Date of Patent
February 10, 2015
Patent Application Number
13815735
Date Filed
March 15, 2013
Patent Citations Received
‌
US Patent 11944612 Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
0
‌
US Patent 12103921 Chemical compounds
0
‌
US Patent 11702405 Chemical compounds
0
Patent Primary Examiner
‌
Heidi Reese
Patent abstract

Provide herein are compounds and pharmaceutical compositions suitable as modulators of hemoglobin, methods and intermediates for their preparation, and methods for their use in treating disorders mediated by hemoglobin and disorders that would benefit from tissue and/or cellular oxygenation.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 8952171 Compounds and uses thereof for the modulation of hemoglobin

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.